Oscar Health Forecasts 60% Revenue Surge to $18.85 B and Profit Return
Oscar Health reported 27% year-over-year revenue growth to $11.7 billion in 2025 but missed Q4 EPS and revenue estimates, remaining unprofitable. It forecasts over 60% revenue growth to $18.85 billion in 2026, a return to profitability, and 58% membership growth to about 3 million via AI cost reductions.
1. Q4 2025 Earnings Results
Oscar Health delivered $11.7 billion in revenue for fiscal 2025, up 27% year-over-year, but fell short of analyst EPS and revenue estimates, resulting in an unprofitable quarter. Operating losses widened as elevated marketing and underwriting expenses offset top-line gains.
2. 2026 Financial Guidance
The company projects revenue exceeding $18.85 billion in 2026, representing over 60% growth, and anticipates a return to profitability with significant operating earnings improvement. Management cites scaling benefits and disciplined expense control as key drivers for the turnaround.
3. Membership Growth and AI Initiatives
Oscar Health expects membership to reach roughly 3 million by year-end 2026, a 58% increase, fueled by expanded exchange enrollment. The company plans to deploy AI-driven cost reduction programs and targeted product offerings to enhance margins and support sustainable growth.